Fluoxetine therapy in depersonalisation disorder: Randomised controlled trial

British Journal of Psychiatry

Volumn 185, Issue JULY, 2004, Pages 31-36

  Simeon, Daphne ^a   Guralnik, Orna ^a   Schmeidler, James ^a   Knutelska, Margaret ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ADVERTIZING; ANOREXIA; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPERSONALIZATION; DEPRESSION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EXCITATION; FATIGUE; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; HYPERACTIVITY; INSOMNIA; LIBIDO DISORDER; MALE; MUSCLE CRAMP; MUSCLE STIFFNESS; NAUSEA; NERVOUSNESS; RANDOMIZED CONTROLLED TRIAL; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STOMACH PAIN; SWEATING; TREATMENT OUTCOME; TREMOR; URINARY FREQUENCY; VISUAL IMPAIRMENT;

ADULT; DEPERSONALIZATION; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 3242722052     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.185.1.31     Document Type: Article

References (29)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.
2. Baker, D., Hunter, E., Lawrence, E., et al (2003) Depersonalisation disorder: clinical features of 204 cases. British Journal of Psychiatry, 182, 428-433.
3. Bernstein-Carlson, E. & Putnam, F. W. (1993) An update on the Dissociative Experiences Scale. Dissociation, 6, 16-27.
4. Cohen, J. (1988) Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale, NJ: Lawrence Erlbaum.
5. Ellason, J. W. & Ross, C. A. (1997) Two-year follow-up of inpatients with dissociative identity disorder. American Journal of Psychiatry, 154, 832-839.
6. Fichtner, C. G., Horevitz, R. P. & Braun, B. G. (1992) Fluoxetine in depersonalisation disorder [letter]. American Journal of Psychiatry, 149, 1750-1751.
7. First, M. B., Spitzer, R. L., Gibbon, M., et al (1995) Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Version (SCID-P), version 2. New York: New York State Psychiatric Institute Biometrics Research.
8. Goodman, W. K., Price, L. H., Rasmussen, S. A., et al (1989) The Yale-Brown Obsessive Compulsive Scale I. Development, use and reliability. Archives of General Psychiatry, 46, 1006-1011.
9. Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. Revised DHEW Pub. (ADM). Rockville, MD: National Institute for Mental Health.
10. Hamilton, M. (1959) The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.
11. Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-61.
12. Heimberg, R. G., Horner, K. J., Juster, H. R., et al (1999) Psychometric properties of the Liebowitz Social Anxiety Scale. Psychological Medicine, 29, 199-212.
13. Hollander, E., Liebowitz, M. R., DeCaria, C., et al (1990) Treatment of depersonalization with serotonin reuptake blockers. Journal of Clinical Psychopharmocology, 10, 200-203.
14. Lubin, H., Loris, M., Burt, J., et al (1998) Efficacy of psychoeducational group therapy in reducing symptoms of posttraumatic stress disorder among multiply traumatized women. American Journal of Psychiatry, 155, 1172-1177.
15. Mayer-Gross, W. (1935) On depersonalization. British Journal of Medical Psychology, 15, 103-126.
16. Pfohl, B., Blum, N. & Zimmerman, M. (1995) Structured Interview for DSM-IV Personality Disorders (SIDP-IV). Iowa City, IA: University of Iowa Department of Psychiatry.
17. Ratliff, N. B. & Kerski, D. (1995) Depersonalization treated with fluoxetine [letter]. American Journal of Psychiatry, 152, 1689-1690.
18. Roth, M. (1959) The phobic - anxiety depersonalization syndrome. Proceedings of the Royal Academy of Medicine, 52, 587-595.
19. Sedman, G. (1972) An investigation of certain factors concerned in the aetiology of depersonalization. Acta Psychiatrica Scandinavica, 48, 191-219.
20. Sierra, M., Phillips, M. L., Krystal, J., et al (2003) A placebo-controlled, crossover trial of lamotrigine in depersonalization disorder. Journal of Psychopharmacology, 17, 103-105.
21. Simeon, D. (2004) Depersonalization disorder: a contemporary overview. CNS Drugs, 18, 343-354.
22. Simeon, D., Gross, S., Guralnik, O., et al (1997) Feeling unreal: 30 cases of DSM-III-R depersonalization disorder. American Journal of Psychiatry, 154, 1107-113.
23. Simeon, D., Stein, D. J. & Hollander, E. (1998a) Treatment of depersonalization disorder with clomipramine. Biological Psychiatry, 44, 302-303.
24. Simeon, D., Guralnik, O., Gross, S., et al (1998b) The detection and measurement of depersonalization disorder. Journal of Nervous and Mental Disease, 186, 536-542.
25. Simeon, D., Guralnik, O. & Schmeidler, J. S. (2001) Development of a depersonalization severity scale. Journal of Traumatic Stress, 14, 341-349.
26. Simeon, D., Knutelska, M., Nelson, D., et al (2003) Feeling unreal: a depersonalization disorder update of 117 cases. Journal of Clinical Psychiatry, 64, 900-907.
27. Steinberg, M. (1994) Structured Clinical Interview for DSM-IV Dissociative Disorders (SCID-D), revised. Washington, DC: American Psychiatric Press.
28. Torch, E. M. (1978) Review of the relationship between obsession and depersonalization. Acta Psychiatrica Scandinavica, 58, 191-198.
29. World Health Organization (1992) Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10). Geneva: WHO.